Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Vasculitis, Central Nervous System 1Stiff-Person Syndrome 1Rasmussen subacute encephalitis 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1Plasmablastic Lymphoma 1Opsoclonus-Myoclonus Syndrome 1Neuromyelitis Optica 1Myasthenia Gravis 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lambert-Eaton Myasthenic Syndrome 1Hodgkin Disease 1HIV Infections 1Burkitt Lymphoma 1Brain Neoplasms 1Autoimmune Diseases of the Nervous System 1Autoimmune Diseases 1

Interventions

Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Biopsy 3Fluorouracil 2Etoposide 2Cyclophosphamide 2liposomal doxorubicin 1fludarabine 1dehydroftorafur 1carmustine, poliferprosan 20 drug combination 1cabozantinib 1axicabtagene ciloleucel 1Zidovudine 1X-Rays 1Vincristine 1Valganciclovir 1Triage 1Therapeutics 1Standard of Care 1Sodium Chloride 1Smoking Devices 1Sirolimus 1Sigmoidoscopy 1Sentinel Lymph Node Biopsy 1Rituximab 1Restraint, Physical 1Raltegravir Potassium 1Radiotherapy, Intensity-Modulated 1Proctoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × carmustine, poliferprosan 20 drug combination × 1 year × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡